Domaine de Maîtrise :
Biopathologie et Recherche Biomédicale

Domaine d’intérêt :
Recherche Clinique, Biopathologie et Recherche Biomédicale**

Les publications :
1. El Hadi H, Abdellaoui-Maane I, Kottwitz D, El Amrani M, Bouchoutrouch N, Qmichou Z, Karkouri M, ElAttar H, Errihani H, Fernandez PL, Bakri Y, Sefrioui H, Moumen A. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer. Gene. 2017;605:114-122. 2. Abdellaoui Maane I et al. Evaluation of combined quantification of PCA3 and AMACR gene for molecular diagnostic of cancer in Morocco. Asian Pac J Cancer Prev 2016;17(12): 5229-5235. 3. D. Kottwitz, H. EL Hadi, M. EL Amrani, S. Cabezas, H. Dehbi, S. Nadifi, A. Quessar, A. Moumen, D. Colomer and H. Sefrioui. Evaluation of a novel multiplex RT-qPCR assay for the quantification of BCR-ABL1 translocation. Int J Hematolol 2015; 102(3):335-41. 4. Moumen A, Dehbi H, Kottwitz D, El Amrani M, Bouchoutrouch N, El Hadi H, Quessar A, Benchekroun S, Nadifi S and Sefrioui H. Quantitative real-time polymerase chain reaction as an efficient molecular tool for detecting minimal residual disease in Moroccan chronic myeloid leukemia patients. Genet Mol Res. 2015 Feb 6;14(1):1044-1055. 5. Tazzit A, Nadifi S, Kottwitz D, et al. BRCA1 gene variations in young Moroccan breast cancer patients. Genet Mol Res. 2014, 31; 13(1):791-8. 6. Sefrioui H. Inflammatory Breast Cancer in North Africa: J Dis Markers. 2014; 1(1). 7. Ait Benhassou H, Bouchoutrouch N, Amar Y and H Sefrioui. Hereditary Breast Cancer in Moroccan Populations: BRCA1 & BRCA2 at the Glance.. Journal of Genetic Syndrome & Gene Therapy 2014; 5:4-7. 8. Molecular Diagnosis and Palliative Care. Abdelaoui Maani I, H. El Hadi, H. Sefrioui, A. Moumen Palleative Medecine & Care 2014; 1 (2):4-7. 9. Sefrioui H, Donahue J, Gilpin E, Carrier E. Tolerance following in utero transplantation of allogeneic fetal cells. Cell Transplantation 2003; 12 (1): 75-82. 10. Sefrioui H, Donahue J, Srivastava A, Gilpin E, Lee Z, Carrier E. Alloreactivity following in utero transplantation of allogeneic hematopoietic stem cells. Experimental Hematology 2002; 30 (6): 617-624. 11. Sefrioui H, Billiau AD, Waer M. Graft-versus-leukemia effect in minor antigen mismatched chimeras: Role of donor ASGM1 & T cells. Transplantation 2000; 70 (2):348-353. 12. Sefrioui H, Billiau AD, Rutgeerts O, Waer M. Influence of the injection of host-type bone marrow on the immune tolerance of chimeras. Transplantation 1999; 68: 1560-1567. 13. Sefrioui H, Billiau AD, overbergh L, Waer M. Host-type bone marrow and tolerance in mixed allogeneic chimeras. Transplant Proc 1998; 31: 702-703. 14. Sefrioui H , Billiau AD, Overbergh L, Waer M. Chimerism induced by lymphoid irradiation or by total body irradiation is maintained by different mechanisms and leads to different GVL or GVH reactions. Transplant Proc 1997; 29 (5): 2352. 15. Billiau AD, Sefrioui H, et al. Role of TGF-beta on Graft-versus-leukemia effect in TBI or TLI chimeras. Transplantation 2001; 71: 292-299.